A sound obesity evaluation measures adiposity (BMI and waist), screens for the conditions obesity causes or worsens — blood pressure, A1c or glucose, lipids, liver, sleep apnea — reviews medications and eating behaviour, and checks the thyroid once. Broad hormone panels are not routine, and are added only when specific signs point to a secondary or endocrine cause.
Two statements, both true
Not every case should be assumed to be lifestyle. A minority of people have a genuine secondary or contributing cause — a drug that drives weight gain, hypothyroidism, Cushing's, PCOS, a hypothalamic or pituitary problem, a genetic syndrome — which changes management. Missing it is its own failure. → When Weight Change Is a Red Flag
Good evaluation lives in the tension between the two, somewhere between testing everything and testing nothing: measuring adiposity properly, screening for the harm obesity does, and reserving deeper endocrine or secondary testing for people whose history or examination points there. → The WeightExperts Clinical Approach
Measuring adiposity, not only BMI
BMI is a useful population screen and the entry point for most guidelines, but a crude individual measure: it does not distinguish fat from muscle, does not show where fat sits, and misclassifies muscular people and some older or Asian populations. → BMI, Body Fat & Body Composition
- Waist circumference, or waist-to-height ratio. Central visceral fat drives most metabolic risk, so waist adds information BMI misses, particularly at "normal" or "overweight" BMI. Grade A 🟢
- Body composition (DXA or BIA). Useful for tracking fat against lean mass during rapid loss, though not required for everyone. BIA is convenient and noisy, DXA more accurate, and a single "lean mass" figure means less than it appears to. Grade B 🟡 → Weight-Loss Lab Library
- Ethnicity-specific thresholds. Metabolic risk appears at lower BMI and waist in South Asian and some other populations, where lower cut-points apply. Grade B 🟡
What matters is not the number on the scale but how much excess adiposity is present and where it sits.
Screening for what obesity does
This is the part almost everyone with obesity should have, because it looks for treatable harm regardless of cause. These findings change management far more often than any endocrine workup does.
- Blood pressure. Obesity-associated hypertension is common and consequential. Grade A 🟢
- Glycaemia, by A1c and/or fasting glucose. Screens for prediabetes and type 2 diabetes, which reframes goals towards remission or prevention and changes treatment choice. Grade A 🟢 → Obesity & Diabetes
- Lipid panel with triglycerides. Dyslipidaemia clusters with visceral adiposity and drives cardiovascular risk. Grade A 🟢 → Obesity & Cardiovascular Health
- Liver: ALT, AST and MASLD risk. Metabolic dysfunction-associated fatty liver is common in obesity, normal liver enzymes do not exclude it, and the outcome that matters is fibrosis rather than fat. A FIB-4, calculated from age, AST, ALT and platelets, risk-stratifies, with elastography reserved for indeterminate or higher risk. Grade A 🟢 → Do I Have Fatty Liver? · FIB-4 Explained
- Obstructive sleep apnea. Under-diagnosed and high-yield: it worsens metabolic health, blood pressure and quality of life, and it is treatable. Symptoms — snoring, witnessed apneas, daytime sleepiness — guide who is tested. Tirzepatide is now FDA-approved for moderate-to-severe OSA in adults with obesity, so the finding can also shape treatment. Grade A 🟢
Medications and behaviour
Two of the highest-yield and lowest-cost parts of the whole evaluation are also the two most often skipped.
- Medication review. Several drug classes cause or worsen weight gain: some antipsychotics, certain antidepressants, some antiseizure drugs, corticosteroids and some diabetes drugs, including insulin and sulfonylureas. A weight-neutral or weight-favourable alternative sometimes exists, making this a correctable contributor. Grade A 🟢 → When Weight Change Is a Red Flag
- Eating behaviour and disordered eating. Screening covers binge-eating disorder, the most common eating disorder and common in people seeking weight treatment, along with night-eating and a history of restriction or purging. Recognition changes the plan: some treatments help binge eating, and starting certain interventions without identifying an eating disorder can do harm. Grade A 🟢 → Mental Health & Obesity
- Physical activity and function. Assessed for baseline activity, strength and mobility, which matter for muscle preservation and maintenance rather than as a weight cure, exercise being a weak weight-loss lever. Grade B 🟡 → Exercise, Muscle & Body Composition
- Sleep, stress and life context. Poor sleep raises appetite, and shift work, stress, food access and socioeconomic factors all shape weight. These are modifiable contributors worth naming. Grade B 🟡
The thyroid, checked once
Thyroid disease is common and easy to check, so a one-time TSH is reasonable in most weight evaluations, read with realistic expectations. Untreated hypothyroidism causes only modest weight gain, much of it fluid; a normal TSH effectively rules it out as a major driver; and treating a normal thyroid does not produce weight loss. Pursuing borderline or subclinical numbers to explain significant obesity rarely leads anywhere, and the answer is usually that the thyroid is normal. Grade A 🟢 → Obesity & Hormones · Thyroid & weight (Hashiexperts)
Targeted endocrine and secondary evaluation
These are added when specific pointers are present, not by reflex.
- PCOS, in women. Considered with irregular cycles, androgen excess such as acne or hirsutism, or fertility concerns. PCOS genuinely entangles hormones and weight, and changes management. Grade A 🟢 → PCOS & Weight
- Menopause and perimenopause. Falling estrogen shifts fat towards the abdomen and changes body composition: context for women in midlife, though not a test. Grade A 🟢 → Menopause & Weight (MenoExperts)
- Testosterone, in men. Checked when symptoms of hypogonadism are present, bearing in mind that the link runs both ways: excess visceral fat lowers testosterone, and weight loss often raises it. Testosterone is not a weight-loss treatment. Grade B 🟡 → Men's Health (TestoExperts — forthcoming)
- Cushing's syndrome. Tested when the clinical picture fits: rapid central weight gain, purple striae, easy bruising, thin skin, proximal muscle weakness, uncontrolled hypertension or diabetes. Uncommon but treatable; routine cortisol testing for common obesity is not useful. Grade A 🟢 → When Weight Change Is a Red Flag
- Hypothalamic and pituitary causes. Considered with rapid or severe weight gain plus headaches, visual changes, menstrual disturbance, milk discharge from raised prolactin, or a history of brain injury, surgery or radiation. Hypothalamic obesity, for instance after craniopharyngioma treatment, and pituitary disease are uncommon but genuinely secondary. Grade B 🟡
- Genetic and syndromic obesity. Considered with early-onset childhood severe obesity, extreme hyperphagia, developmental features or a strong family pattern. Monogenic forms (MC4R, leptin and LEPR, POMC) and syndromic forms (Prader-Willi, Bardet-Biedl) exist, and some — POMC, LEPR, Bardet-Biedl — have a targeted treatment in setmelanotide. Grade B 🟡 → Genetics of Obesity
What is not useful: reflex broad "hormone panels," fasting-insulin and HOMA-IR fishing, "adrenal fatigue" testing, and commercial "hormone imbalance" or "functional-medicine metabolic" panels offered as the key to weight loss. The evidence does not support them here; they generate false positives and rarely change management. Grade A 🟢 → Weight-Loss Lab Library
What the evidence says
- What we know: measuring waist alongside BMI, and screening for the harms obesity causes — blood pressure, glycaemia, lipids, liver and MASLD, sleep apnea — reliably changes management. A one-time thyroid check is reasonable, and medication and eating-behaviour review are cheap and high-yield.
- What we think: deeper endocrine or secondary testing belongs where clinical pointers exist, while a real secondary cause should not be missed by assuming lifestyle.
- What we don't know: the optimal agreed panel, body-composition thresholds that change outcomes for everyone, and the best way to put risk-based selection into practice.
- For any proposed test: the question is which result would change the plan. A test that would not alter goals, treatment or referral adds cost, incidental findings and anxiety. → The WeightExperts Clinical Approach
Questions patients ask
Is a full hormone panel needed to explain weight gain?
Usually not. Broad reflex hormone testing mostly returns normal and rarely changes management, and deeper endocrine testing is added only when specific signs point to a condition such as PCOS, Cushing's or a pituitary problem. Grade A 🟢 → Obesity & Hormones
If all the labs are normal, does that mean it's a willpower problem?
No. Genetics, appetite biology, environment and medications drive most obesity with entirely normal standard tests. Grade A 🟢 → Obesity as a Chronic Disease
When does obesity actually need a deeper secondary workup?
When the story points there: a weight-driving medication, features of hypothyroidism or Cushing's, PCOS symptoms, rapid or severe gain with neurological or pituitary features, or early-onset severe obesity suggesting a genetic cause. Grade B 🟡 → When Weight Change Is a Red Flag
Which of these tests belongs in a particular evaluation depends on history, examination and risk profile, and is decided individually at the practice.
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: 2026-08-10 · References: AACE/ACE and Obesity Medicine Association obesity evaluation guidance; Endocrine Society statements on obesity and secondary causes; AASLD Practice Guidance on MASLD (2023) and FIB-4 risk stratification; PCOS diagnostic guidelines; screening literature for obstructive sleep apnea and binge-eating disorder. Cross-references: Hashiexperts (thyroid), MenoExperts (menopause), TestoExperts (men's hormones — forthcoming). Educational; not individualized medical advice.
